Although SAMDH1 mutations were found at lower frequencies compared to established CLL driver genes (like MYD88, TP53, or ATM), it was still classified as a potential driving cause in CLL [44]. This evidence concerns the gene TP53 and B-cell chronic lymphocytic leukemia.